Rethinking Personalized Medicine: AI’s Limits in Clinical Trials Neuroscience News Nawigacja wpisu Alzheimer’s patients divided into 5 subgroups, potentially enabling ‘personalized medicine,’ study finds – Fox News Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19 | NEJM – nejm.org
